NASDAQ:JYNT

Joint - JYNT Stock Forecast, Price & News

$20.22

-1.39 (-6.43%)

(As of 08/19/2022 12:00 AM ET)

Add

Compare

Today's Range: $20.16
▼
$21.08
50-Day Range: $13.25
▼
$22.61
52-Week Range: $13.10
▼
$111.06

Volume: 81,741 shs
Average Volume: 268,699 shs
Market Capitalization: $292.40 million

P/E Ratio: 134.81
Dividend Yield: N/A
Price Target: $33.17

Joint MarketRank™ Forecast

Analyst Rating: Hold
2.40 Rating Score
Upside/Downside: 64.0% Upside
$33.17 Price Target
Short Interest: Bearish
7.40% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.15
Based on 14 Articles This Week
Insider Trading: Acquiring Shares
$423,740 Bought Last Quarter
Proj. Earnings Growth: 121.43%
From $0.14 to $0.31 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars

Medical Sector

181st out of 1,116 stocks

Patent Owners & Lessors Industry

4th out of 5 stocks

3.2

Analyst's Opinion

Consensus Rating
Joint has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $33.17, Joint has a forecasted upside of 64.0% from its current price of $20.22.
Amount of Analyst Coverage
Joint has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
7.40% of the float of Joint has been sold short.
Short Interest Ratio / Days to Cover
Joint has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month

0.0

Dividend Strength

Dividend Yield
Joint does not currently pay a dividend.
Dividend Growth
Joint does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for JYNT.

2.9

News and Social Media Coverage

News Sentiment
Joint has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 14 news articles for Joint this week, compared to 9 articles on an average week.
Search Interest
1 people have searched for JYNT on MarketBeat in the last 30 days.
MarketBeat Follows
4 people have added Joint to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Joint insiders have bought more of their company's stock than they have sold. Specifically, they have bought $423,740.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 3.50% of the stock of Joint is held by insiders.
Percentage Held by Institutions
86.39% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Joint are expected to grow by 121.43% in the coming year, from $0.14 to $0.31 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Joint is 134.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 141.94.
Price to Earnings Ratio vs. Sector
The P/E ratio of Joint is 134.81, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 95.91.
Price to Book Value per Share Ratio
Joint has a P/B Ratio of 9.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Joint (NASDAQ:JYNT) Stock

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Joint Stock Up 1.7 %

Shares of NASDAQ:JYNT opened at $21.61 on Friday. The company has a quick ratio of 0.87, a current ratio of 0.87 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $312.41 million, a P/E ratio of 144.04 and a beta of 1.33. Joint has a 52-week low of $13.10 and a 52-week high of $111.06. The stock's fifty day simple moving average is $16.74 and its 200-day simple moving average is $27.28.

Wall Street Analyst Weigh In

JYNT has been the topic of a number of recent analyst reports. Lake Street Capital lowered their price target on shares of Joint from $100.00 to $50.00 in a research note on Friday, May 6th. Craig Hallum downgraded shares of Joint from a "buy" rating to a "hold" rating and reduced their price target for the company from $90.00 to $30.00 in a research report on Friday, May 6th. Roth Capital decreased their price target on Joint from $75.00 to $40.00 in a research note on Monday, May 9th. StockNews.com cut Joint from a "hold" rating to a "sell" rating in a report on Friday, August 12th. Finally, B. Riley raised Joint from a "neutral" rating to a "buy" rating and set a $31.00 target price on the stock in a report on Friday, August 5th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $33.17.

Insider Activity at Joint

In other news, major shareholder Bandera Partners Llc purchased 6,593 shares of the firm's stock in a transaction on Monday, June 13th. The shares were bought at an average cost of $13.86 per share, with a total value of $91,378.98. Following the purchase, the insider now directly owns 2,111,868 shares of the company's stock, valued at $29,270,490.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.50% of the stock is currently owned by corporate insiders.

Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Stock News Headlines

August 19, 2022 | cowboyswire.usatoday.com

Cowboys-Chargers photo gallery from 2 days of joint practice - Cowboys Wire

August 19, 2022 | marketwatch.com

Should you set up a joint account with your adult child? - MarketWatch

August 19, 2022 | theeagleswire.usatoday.com

Takeaways and observations from Eagles first joint practice with Browns - Eagles Wire

August 18, 2022 | brownswire.usatoday.com

Browns, Eagles joint practices begin: Interesting things to watch for - Browns Wire

August 18, 2022 | packerswire.usatoday.com

Important things to know from Packers' joint practices with Saints - Packers Wire

August 18, 2022 | packerswire.usatoday.com

Best photos from Packers' joint practices with Saints - Packers Wire

August 17, 2022 | theeagleswire.usatoday.com

10 key matchups to watch as Eagles-Browns begin joint practices - Eagles Wire

August 17, 2022 | packerswire.usatoday.com

Live updates from Packers' joint practice No. 2 with Saints - Packers Wire

August 17, 2022 | cowboyswire.usatoday.com

5 key matchups to watch as Cowboys-Chargers begin joint practices - Cowboys Wire

August 17, 2022 | forbes.com

Joint Credit Card: What To Know Before You Get One - Forbes

August 17, 2022 | nbcnews.com

China to send troops to Russia for joint military exercise - NBC News

August 16, 2022 | packerswire.usatoday.com

Live updates from Packers' joint practice No. 1 with Saints - Packers Wire

August 15, 2022 | americanbankingnews.com

StockNews.com Lowers Joint (NASDAQ:JYNT) to Sell

August 13, 2022 | usnews.com

Newton Man Turns Former Store, Juke Joint Into Time Capsule - U.S. News & World Report

August 12, 2022 | americanbankingnews.com

The Joint Corp. (NASDAQ:JYNT) Receives $33.17 Consensus PT from Brokerages

August 12, 2022 | americanbankingnews.com

The Joint Corp. (NASDAQ:JYNT) Receives $33.17 Consensus Target Price from Brokerages

August 11, 2022 | reuters.com

China's Didi EV joint venture with Li Auto applies for bankruptcy - court - Reuters

August 11, 2022 | broncoswire.usatoday.com

Denver Broncos: Joint practice will bring ‘great competition’ - Broncos Wire

August 11, 2022 | dolphinswire.usatoday.com

Notes from Day 2 of Dolphins-Buccaneers joint practices - Dolphins Wire

August 10, 2022 | americanbankingnews.com

Joint (NASDAQ:JYNT) Price Target Cut to $12.00

August 9, 2022 | usnews.com

Joint Practices Allow Coaches to Hold Players Out of Games - U.S. News & World Report

August 9, 2022 | finance.yahoo.com

Joint Pain Injections Market Expands due to Rising Prevalence of Knee-related Diseases, States TMR Study - Yahoo Finance

August 9, 2022 | broncoswire.usatoday.com

Denver Broncos: Team to host Dallas Cowboys for joint practice - Broncos Wire

August 9, 2022 | americanbankingnews.com

Joint (NASDAQ:JYNT) Upgraded by Maxim Group to Buy

August 9, 2022 | americanbankingnews.com

Q3 2022 Earnings Forecast for The Joint Corp. Issued By B. Riley (NASDAQ:JYNT)

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Company Calendar

Last Earnings: 11/04/2021
Today: 8/19/2022
Next Earnings (Estimated): 11/03/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Patent owners & lessors
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:JYNT
CUSIP: N/A
CIK: 1612630
Web: www.thejoint.com
Phone: (480) 245-5960
Fax: 480-513-7989
Employees: 316
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $33.17
High Stock Price Forecast: $50.00
Low Stock Price Forecast: $12.00
Forecasted Upside/Downside: +64.0%
Consensus Rating: Hold
Rating Score (0-4): 2.40
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.15
Trailing P/E Ratio: 134.81
Forward P/E Ratio: 144.43
P/E Growth: N/A
Net Income: $6.58 million
Net Margins: 2.53%
Pretax Margin: 1.73%
Return on Equity: 7.74%
Return on Assets: 2.72%

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 0.87
Quick Ratio: 0.87

Sales & Book Value

Annual Sales: $81.19 million
Price / Sales: 3.60
Cash Flow: $0.87 per share
Price / Cash Flow: 23.12
Book Value: $2.11 per share
Price / Book: 9.58

Miscellaneous

Outstanding Shares: 14,461,000
Free Float: 13,955,000
Market Cap: $292.40 million
Optionable: Not Optionable
Beta: 1.33

Key Executives

Mr. Peter D. Holt (Age 63)
CEO, Pres & Director
Comp: $751.31k

Jake Singleton (Age 40)
Chief Financial Officer
Comp: $379.76k

Mr. Jorge Armenteros
VP of Operations

Mr. Charles Nelles
Chief Technology Officer

Dr. Steven Knauf
Exec. Director of Chiropractic & Compliance

Mr. Jason Greenwood
Chief Marketing Officer

Ms. Amy Karroum
VP of HR

Mr. Craig P. Colmar J.D. (Age 69)
Sec.

Mr. Eric Simon
VP of Franchise Sales & Devel.

Ms. Manjula Sriram
Vice Preident of Information Technology

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

JYNT Stock - Frequently Asked Questions

Should I buy or sell Joint stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares.
View JYNT analyst ratings or view top-rated stocks.
What is Joint's stock price forecast for 2022?: 5 Wall Street analysts have issued 12-month target prices for Joint's shares. Their JYNT share price forecasts range from $12.00 to $50.00. On average, they anticipate the company's stock price to reach $33.17 in the next year. This suggests a possible upside of 64.0% from the stock's current price.
View analysts price targets for JYNT or view top-rated stocks among Wall Street analysts.
How have JYNT shares performed in 2022?: Joint's stock was trading at $65.69 on January 1st, 2022. Since then, JYNT shares have decreased by 69.2% and is now trading at $20.22.
View the best growth stocks for 2022 here.
When is Joint's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our JYNT earnings forecast.
How were Joint's earnings last quarter?: The Joint Corp. (NASDAQ:JYNT) posted its quarterly earnings results on Thursday, November, 4th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.04 by $0.09. The company earned $20.99 million during the quarter, compared to the consensus estimate of $19.48 million. Joint had a trailing twelve-month return on equity of 7.74% and a net margin of 2.53%. During the same period in the prior year, the business earned $0.11 EPS.
What guidance has Joint issued on next quarter's earnings?: Joint issued an update on its FY 2022 earnings guidance on Thursday, August, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $98.00 million-$102.00 million, compared to the consensus revenue estimate of $99.06 million.
What is Peter D. Holt's approval rating as Joint's CEO?: 87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Joint own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Raytheon Technologies (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).
When did Joint IPO?: (JYNT) raised $20 million in an initial public offering (IPO) on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.
What is Joint's stock symbol?: Joint trades on the NASDAQ under the ticker symbol "JYNT."
Who are Joint's major shareholders?: Joint's stock is owned by a number of institutional and retail investors. Top institutional investors include State Street Corp (3.12%), Skylands Capital LLC (2.85%), Deutsche Bank AG (1.56%), Walleye Capital LLC (1.36%), Walleye Capital LLC (1.36%) and Northern Trust Corp (1.03%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella.
View institutional ownership trends.
How do I buy shares of Joint?: Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Joint's stock price today?: One share of JYNT stock can currently be purchased for approximately $20.22.
How much money does Joint make?: Joint (NASDAQ:JYNT) has a market capitalization of $292.40 million and generates $81.19 million in revenue each year. The company earns $6.58 million in net income (profit) each year or $0.15 on an earnings per share basis.
How many employees does Joint have?: The company employs 316 workers across the globe.
How can I contact Joint?: Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The official website for the company is www.thejoint.com. The company can be reached via phone at (480) 245-5960, via email at thejoint@lhai.com, or via fax at 480-513-7989.

This page (NASDAQ:JYNT) was last updated on 8/19/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Joint - JYNT Stock Forecast, Price & News

Joint MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month